PACADD-159

Cat.No.: CSC-C6237X

Species: Homo sapiens (Human)

Source: Pancreas

Morphology: epitheloid cells growing adherently in monolayers

Culture Properties: monolayer

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C6237X
Description
Established in 2012 from a primary pancreatic tumor of a 78-year-old Caucasian man with ductal adenocarcinoma located at the tail of the pancreas (intermediate grade G2, pT3N1M0)
Species
Homo sapiens (Human)
Source
Pancreas
Recommended Medium
80% mixture of DMEM and Keratinocyte SFM (at 1:1) + 20% h.i. FBS
Culture Properties
monolayer
Morphology
epitheloid cells growing adherently in monolayers
Disease
Pancreatic Ductal Adenocarcinoma
Quality Control
Mycoplasma: negative in PCR assay
Immunology: cytokeratin +, desmin -, endothel -, GFAP -, neurofilament -, vimentin -
Viruses: PCR: EBV -, HBV -, HCV -, HIV -, HTLV-I/-II -
Storage and Shipping
Frozen with 70% medium, 20% FBS, 10% DMSO at about 1 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen
Synonyms
PaCaDD-159; PACADD159
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

PACADD-159 (aka PaCaDD-159) is a pancreatic cancer cell line from a pancreatic ductal adenocarcinoma (PDAC) patient tumor. Specifically, the original tumor was a primary PDAC tumor from a male who was 78 years old at the time of diagnosis/tumor procurement. It was derived by the Dresden outgrowth protocol and created as part of a collection of primary PDAC tumor cell lines with the intent of modeling tumor heterogeneity and clinical pathology more accurately. It has epithelial like morphology and forms adherent monolayer cultures. PACADD-159 has slower growth compared to other pancreatic cancer cells lines and poor ability to form 3D tumor spheres, indicating possible higher microenvironment dependency.

As anticipated for a pancreatic cancer cell line, it carries oncogenic KRAS mutations. Transcriptomic analysis has shown upregulation of NF-κB, PI3K-Akt signaling, and genes involved in tumor progression, EMT, and drug resistance. The cell line has recently been used for differential transcriptomic and proteomic profiling comparing tumor heterogeneity, drug response differences, and secretome analysis between pancreatic cancer cell lines.

Growth Characteristics of Primary and Expandable Pancreatic Cancer Cell Lines

Guo's team addresses the challenge that primary pancreatic cancer cells become highly vulnerable and difficult to maintain after losing their tumor microenvironment. They investigated whether lentiviral transduction could generate expandable primary pancreatic cancer cell lines retaining original tumor-specific characteristics, including chemosensitivity, for patient-specific chemotherapy screening.

Figure 1 shows the study flowchart. Cell morphology was assessed in 2D culture (Figure 2A). Primary MaPac107 (Pri-MaPac107) exhibited epithelial monolayer characteristics with a fusiform-organized pattern, growing in clusters before confluency with irregularly shaped nuclei; this pattern disappeared at confluence. Expandable MaPac107 (Ex-MaPac107) shared identical morphology. Primary PaCaDD159 (Pri-PaCaDD159) proliferated as epithelial monolayers with lumpy, cluster-like organization, featuring ovoid cells with small round nuclei; Ex-PaCaDD159 showed matching morphology. Primary PaCaDD165 (Pri-PaCaDD165) grew as small polygonal cells with a cobblestone pattern, prominent nuclei, and rapid proliferation; Ex-PaCaDD165 showed no morphological differences.

Growth curves and doubling times are shown in Figure 2B, C. Ex-MaPac107 and Ex-PaCaDD165 exhibited higher proliferation rates than their primary counterparts, while Ex-PaCaDD159 proliferated significantly slower than Pri-PaCaDD159. Despite this unexpected reduction, the remaining two expandable lines demonstrated enhanced proliferation in 2D culture.

Morphology and growth characteristics of primary and expandable pancreatic cancer cells in 2D culture.

Fig. 1. Morphology and growth characteristics of primary and expandable pancreatic cancer cells in 2D culture (Guo F, Kan K, et al., 2023).

Morphology and growth characteristics of primary and expandable pancreatic cancer cells in 2D culture.

Fig. 2. Morphology and growth characteristics of primary and expandable pancreatic cancer cells in 2D culture (Guo F, Kan K, et al., 2023).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products